Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Pisa
Clinical trial register · Italy

Clinical Trials in Pisa, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6778 matching records held by the registry are in this view. Synced 08 Oct 2026, 03:19 UTC
6778
Studies in scope
all four open statuses
4069
Recruiting now
open to new participants
1018
Lead sponsors
across recruiting studies
Top sites
Milan 2843 Bologna 1305 Roma 1274 Naples 984 Rome 967
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca23 University of Pisa20 Bristol-Myers Squibb17 Novartis Pharmaceuticals11 Janssen Research & Development, LLC10
Site location
Milan2843 Bologna1305 Roma1274 Naples984 Rome967
All 489 locations
Target enrolment
to

Trials with a site in Pisa

393 of 6778 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Not yet open
Alexion Pharmaceuticals, Inc.
Phase 3
1,180
Bologna, Forlì, Florence, Rome, Messina, Naples, Padova, Pisa
2027-11-23
Not yet open
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Phase 3
92
Rome, Milan, Pisa
2027-02-03
Not yet open
Chiesi Farmaceutici S.p.A.
Phase 3
700
Brescia, Brindisi, Genoa, Messina, Milan, Naples, Parma, Pisa
2026-11-16
Not yet open
Boehringer Ingelheim
Phase 3
270
Bari, Catania, Padova, Pavia, Pisa, Torino
2026-11-09
Not yet open
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Phase 3
168
Bologna, Pisa, Torino
2026-10-01
Not yet open
Neoadjuvant Pembrolizumab and Porustobart in Resectable pMMR/MSS Colon Cancer
NCT07808151Colon Cancer, Microsatellite Stable (MSS) Colon Cancer, Proficient Mismatch Repair (pMMR) Colon Cancer
DrugsPorustobart·Keytruda·Pembrolizumab
Solstice Oncology, Inc.
Phase 2
100
Milan, Naples, Pisa
2026-09-30
Not yet open
Probiotics for Sustained Health
NCT07835100Upper Respiratory Tract Infection (URTI)
BioGaia AB
Not applicable
70
Naples, Pisa
2026-09-25
Recruiting
Daiichi Sankyo
Phase 1/2
220
Aviano, Meldola, Milan, Monza, Padova, Pisa
2026-09-17
Recruiting
University of Pisa
Observational
30
Pisa
2026-09-01
Recruiting
AstraZeneca
Phase 3
2,500
Bologna, Milan, Palermo, Pisa, Roma, Rozzano, Sesto San Giovanni, Torino
2026-08-19
Recruiting
SPIKE FLOW Endocardial Lead Safety and Performance Study
NCT07820072Acute Myocardial Infarction (AMI), Asystole, Bradycardia, AV Block
FIAB SpA
Not applicable
131
Acquaviva delle Fonti, Massa, Pisa
2026-08-07
Recruiting
UCB BIOSCIENCES, Inc.
Phase 3
200
Genova, Milan, Naples, Pisa, Troina
2026-07-14
Recruiting
VirtualPark_Pediatric
NCT07580365Dystrophinopathy, Muscular Dystrophies, Congenital Myopathies
Istituto di Sistemi e Tecnologie Industriali Intelligenti per il Manifatturiero Avanzato
Not applicable
22
Bosisio Parini, Pisa, Pavia, Salerno
2026-06-30
Recruiting
AstraZeneca
Phase 3
4,500
Bologna, Catania, Chieti, Florence, Latina, Milan, Pisa, Ravenna
2026-06-29
Recruiting
Safety and Performances of the LINEA Cardiac Pacing Lead Optimized for the Implantation in Interventricular Septum
NCT07342608Bradycardia, Left Bundle Branch Area Pacing, Left Bundle Branch Pacing
MicroPort CRM
Not applicable
450
Novara, Pisa
2026-06-23
Recruiting
Pharming Technologies B.V.
Phase 2
140
Messina, Milan, Pisa
2026-06-12
Active, closed
AstraZeneca
Phase 2
326
Bologna, Florence, Milan, Padova, Pavia, Pisa, Torino, Torrette - Ancona
2026-06-11
Recruiting
Panuri Performance Study
NCT07587866Pancreatic Ductal Adenocarcinoma (PDAC)
Urteste S.A
Observational
1,100
Forlì, Milan, Pavia, Pisa, Roma, Rozzano
2026-06-10
Not yet open
Evaluation of the Impact of Virtual Park on Training Motivation in Adult Patients
NCT07616050Post-stroke, Parkinson Disease, Amyotrophic Lateral Sclerosis, Mild Cognitive Impairment (MCI)
Marta Mondellini
Not applicable
70
Bari, Telese Terme, Costa Masnaga, Milan, Montescano, Pavia, Pisa
2026-06
Recruiting
Novo Nordisk A/S
Phase 3
2,500
Bologna, Genoa, Brescia, Milan, Perugia, Messina, Ancorna, Pisa
2026-05-21
Recruiting
Proprioception and Manual Skills
NCT07182084Proprioception, Physiotherapist, Health Professionals
Kahramanmaras Sutcu Imam University
Observational
36
Pisa
2026-05-15
Not yet open
Gruppo Oncologico Italiano di Ricerca Clinica
Phase 2
108
Bologna, Cuneo, Meldola, Cona, Lido di Camaiore, Lucca, Mantua, Pisa
2026-05
Not yet open
IRCCS Fondazione Stella Maris
Not applicable
14
Pisa
2026-05
Recruiting
Establishing a Reference Framework for Outcomes After Machine-Preserved Liver Transplantation in Europe
NCT07585890End-stage Liver Disease (ESLD), Acute Liver Failure, Liver Cirrhosis, Liver Transplantation
University Medical Center Groningen
Observational
10,000
Bari, Bergamo, Pisa, Torino
2026-04-21
Recruiting
PACE Study: School-Based Mindfulness and Compassion Interventions for Children
NCT07398781School-based Intervention, Mindfulness-based Intervention, Compassion, Emotion Regulation
IRCCS Fondazione Stella Maris
Not applicable
500
Florence, Pisa, Roma
2026-04-13
Recruiting
AstraZeneca
Phase 3
245
Brescia, Catania, Ferrara, Florence, Milan, Padova, Pisa, Roma
2026-04-13
Recruiting
Incyte Corporation
Phase 3
588
Bologna, Brescia, Candiolo, Foggia, Milan, Naples, Pisa, Roma
2026-04-09
Not yet open
Pharmacological Optimization in Prevention in Heart Failure: A Sex-gap?
NCT07295522Heart Failure, Acute Heart Failure, Heart Failure With Reduced Ejection Fraction (HFrEF), Heart Failure With Preserved Ejection Fraction (HFPEF)
DrugGDMT
IRCCS Policlinico S. Donato
Phase 4
368
San Donato Milanese, Ancona, Bari, Cecina, Ferrara, Florence, Milan, Pisa
2026-04-08
Not yet open
Azienda Ospedaliero, Universitaria Pisana
Observational
8,000
Pisa
2026-04-01
Recruiting
Oral Biopsy Bleeding in Patients on Direct Oral Anticoagulants (DOACs)
NCT07520890Direct Oral Anticoagulants (DOACs), Oral Surgical Procedures
University of Pisa
Observational
100
Pisa
2026-04-01
Recruiting
Bristol-Myers Squibb
Phase 1/2
198
Meldola, Pisa, Milan
2026-03-16
Recruiting
Hoffmann-La Roche
Phase 3
2,000
Bergamo, Bari, Catanzaro, Bologna, Rome, San Donato Milanese (MI), Palermo, Pisa
2026-03-16
Recruiting
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
NCT07288398Pulmonary Hypertension Associated With HFpEF
DrugTNX-103
Tenax Therapeutics, Inc.
Phase 3
540
Acquaviva delle Fonti, Bergamo, Messina, Milan, Pavia, Pisa, Roma, Rozzano
2026-03-03
Recruiting
Progel Platinum for Air Leak Reduction After VATS Lobectomy for NSCLC
NCT07479277Non-Small Cell Lung Cancer, Postoperative Air Leak, NSCLC
Fondazione del Piemonte per l'Oncologia
Not applicable
160
Candiolo, Bolzano, Florence, Milan, Palermo, Pisa
2026-02-27
Recruiting
Janssen Research & Development, LLC
Phase 3
400
Alessandria, Brescia, Milan, Pisa, Reggio Emilia, Roma, Rozzano, San Giovanni Rotondo
2026-02-04
Recruiting
Upfront Targeted Axillary Dissection for Luminal Breast Cancer With Limited Axillary Involvement
NCT07278726ALND, Sentinel Lymph Node Biopsy (SLNB), Targeted Axillary Dissection (TAD)
European Institute of Oncology
Observational
150
Bologna, Forlì, Milan, Naples, Ortona, Pavia, Pisa, Roma
2026-01-28
Recruiting
IDEAYA Biosciences
Phase 3
520
Naples, Milan, Perugia, Florence, Pisa, Rome
2026-01-25
Recruiting
University of Pisa
Not applicable
9
Pisa
2026-01-09
Not yet open
Tridimensional Robotic Assessment of Neglect in Brain Injured Patients
NCT07290218Neglect, Brain Injured Patients, Stroke, Unilateral Spatial Neglect (USN)
Fondazione Don Carlo Gnocchi ETS
Observational
15
Sant'Angelo dei Lombardi, Florence, Pisa
2026-01-01
Recruiting
Bristol-Myers Squibb
Phase 2/3
990
Castellana Grotte, San Giovanni Rotondo, Tricase, Milan, Aviano, Pisa, Padova, Avellino
2025-12-31
Recruiting
AstraZeneca
Phase 3
1,100
Brescia, Catania, Florence, Lecco, Milan, Naples, Parma, Pisa
2025-12-29
Recruiting
Sanofi
Phase 2
144
Torette, Cona, Garbagnate Milanese, Milan, Brescia, Chieti, Pisa
2025-12-29
Recruiting
UNICANCER
Phase 3
3,902
Aviano, Caserta, Genova, Naples, Padova, Pisa, Pontedera, Roma
2025-12-18
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
NCT07252232Pancreatic Cancer, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, Resectable Pancreatic Ductal Adenocarcinoma (PDAC)
DrugCetuximab
Revolution Medicines, Inc.
Phase 3
500
Milan, Padova, Pisa, Verona
2025-12-15
Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
NCT07218380Carcinoma, Transitional Cell, Urinary Bladder Neoplasms, Neoplasm Metastasis
DrugsVepugratinib·Pembrolizumab
Eli Lilly and Company
Phase 3
450
Bari, Milan, Naples, Padova, Pisa, Roma, Rome
2025-12-12
Recruiting
AstraZeneca
Phase 2
230
Modena, Naples, Palermo, Pisa, Roma, Varese
2025-12-10
Recruiting
AstraZeneca
Phase 3
1,100
Castellana Grotte, Milan, Pisa, Rome, Rozzano
2025-12-04
Recruiting
University Hospital, Basel, Switzerland
Not applicable
18,000
Pisa
2025-12-03
Recruiting
Bristol-Myers Squibb
Phase 3
650
Naples, Rome, Milan, Pisa, Brescia, Isernia, Roma
2025-12-02
Recruiting
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
NCT07169851Nausea, Vomiting, Drug-Related Side Effects and Adverse Reactions, Neoplasms
Eli Lilly and Company
Phase 2
204
Ancona, Modena, Pisa, Vicenza
2025-11-28
Recruiting
Alexion Pharmaceuticals, Inc.
Phase 2
75
Brescia, Padova, Pavia, Pisa
2025-11-26
Recruiting
Optimal Time for Reperfusion in Acute Pulmonary Embolism
NCT07436702Pulmonary Embolism (Diagnosis), Pulmonary Embolism Acute
Azienda ULSS 8 Berica
Observational
500
Milan, Monselice, Pavia, Perugia, Pisa, Torino, Arzignano
2025-11-25
Recruiting
Summit Therapeutics
Phase 3
600
Roma, Aviano, Brescia, Florence, Genova, Meldola, Milan, Pisa
2025-11-18
Recruiting
ADRIS Driving Simulator for Adolescents With Attention Deficit and Hyperactivity Disorder
NCT07478458ADHD - Attention Deficit Disorder With Hyperactivity
Istituto Giannina Gaslini
Not applicable
120
Genoa, Pisa
2025-11-10
Recruiting
BioNTech SE
Phase 3
558
Aviano, Lucca, Milan, Monza, Pisa, Roma, Torrette
2025-10-30
By invitation
Clinical Trial of Vormatrigine in Adult Patients With Epilepsy
NCT07287163Epilepsy, Tonic-Clonic, Focal Seizure, Primary Generalized Seizure
Praxis Precision Medicines
Phase 3
700
Pozzilli, Bosisio Parini, Milan, Naples, Pavia, Pisa, Ponderano, Roma
2025-10-27
Active, closed
Bristol-Myers Squibb
Phase 2/3
470
Meldola, Rome, Milan, Rozzano, Pisa, Padova, Naples, Verona
2025-10-23
Recruiting
University of Pisa
Observational
70
Pisa
2025-10-15
Recruiting
Emotional Dysregulation and Other Psychopathological Dimensions in Clinical Preschoolers
NCT07805668Behavioral and Emotional Disorder With Onset in Childhood
IRCCS Fondazione Stella Maris
Observational
40
Pisa
2025-10-14
Recruiting
Bristol-Myers Squibb
Phase 3
424
Milan, Pisa, Siena, Ancona, Genova
2025-10-08
Active, closed
Genetic and Clinical Correlates of Disruptive Behavior Disorder With and Without Callous-Unemotional Traits
NCT07322055Conduct Disorder, Oppositional Defiant Disorder, Callous Unemotional Traits
IRCCS Fondazione Stella Maris
Observational
200
Pisa
2025-10-07
Recruiting
ICU Delirium Playbook Training Study for ICU Nurses
NCT07759310Nursing Education, Delirium Confusional State, ICU
Nicola Pagnucci
Not applicable
60
Pisa
2025-10-01
Not yet open
Università degli Studi 'G. d'Annunzio' Chieti e Pescara
Not applicable
360
Chieti Scalo, Pisa, Sassari
2025-10-01
Recruiting
Bristol-Myers Squibb
Phase 2/3
470
Bari, Genoa, Rome, Pisa, Castelfranco Veneto, Milan, Naples, Parma
2025-09-30
Recruiting
Sanofi
Phase 2
30
Milan, Merano, Palermo, Pisa
2025-09-02
Not yet open
Fondazione Don Carlo Gnocchi ETS
Not applicable
100
Sant'Angelo dei Lombardi, Rovato, Florence, Tricarico, Pisa, Acerenza, Roma, La Spezia
2025-09
Recruiting
BeOne Medicines
Phase 3
351
Genova, Milan, Pisa, Rozzano
2025-08-27
Recruiting
Mirum Pharmaceuticals, Inc.
Phase 3
172
Bergamo, Milan, Pisa, Roma
2025-08-27
Recruiting
Basilea Pharmaceutica
Phase 3
234
Genova, Milan, Modena, Pavia, Pisa, Trieste
2025-08-26
Recruiting
GlaxoSmithKline
Phase 3
420
Milan, Bergamo, Genova, Orbassano, Pisa, Siena, Verona
2025-08-11
By invitation
Rede Optimus Hospitalar SA
Not applicable
620
Palermo, Pisa, Catania, Mestre, Roma, Siena, Trieste
2025-08-08
Recruiting
Amgen
Phase 1
434
Milan, Pisa, Verona
2025-07-31
Active, closed
Vir Biotechnology, Inc.
Phase 3
150
Bergamo, Foggia, Milan, Pisa, Torino
2025-07-30
Recruiting
Celgene
Phase 3
400
Bologna, Meldola, Rozzano, Pisa, Alessandria, Naples, Torino
2025-07-28
Recruiting
Bristol-Myers Squibb
Phase 3
450
Milan, Pisa, Siena, Ancona, Genova
2025-07-18
Recruiting
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
NCT06765109Non-small Cell Lung Cancer, Anaplastic Lymphoma Kinase-positive
DrugsNeladalkib·Alectinib
Nuvalent Inc.
Phase 3
450
Ancona, Bari, Meldola, Milan, Monza, Pisa, Ravenna, Roma
2025-07-17
Recruiting
AstraZeneca
Phase 2
100
Florence, Milan, Modena, Pisa, Rozzano, Udine, Vicenza
2025-07-17
Recruiting
Bristol-Myers Squibb
Phase 3
426
Naples, Rome, Milan, Pisa, Brescia, Isernia, Roma
2025-07-16
Active, closed
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Phase 2
89
Rome, Milan, Pisa
2025-07-14
Active, closed
Glycomine, Inc.
Phase 2/3
50
Catania, Pisa
2025-07-09
Recruiting
Carmelo Chisari
Not applicable
20
Costa Masnaga, Pisa
2025-07-07
By invitation
University of Pisa
Observational
30
Pisa
2025-07-01
Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
NCT06966700Breast Neoplasms, Triple Negative Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms
DrugsEpirubicin·Adriamycin·Xeloda·Sacituzumab tirumotecan
Merck Sharp & Dohme LLC
Phase 3
2,400
Monza, Livorno, Ancona, Bergamo, Genova, Milan, Pisa, Reggio Emilia
2025-06-30
Active, closed
Mundipharma Research Limited
Phase 2
60
Genova, Pisa, Roma, Rozzano
2025-06-30
Recruiting
Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer
NCT06995677Low-grade NMIBC, FGFR Gene Amplification, FGFR Gene Alterations, FGFR3 Gene Alteration
DrugTYRA-300
Tyra Biosciences, Inc
Phase 2
90
Rome, Milan, Pisa, Pozzuoli
2025-06-27
Recruiting
Eli Lilly and Company
Phase 3
290
Bologna, Castellana Grotte, Milan, Padova, Pisa, Rho, Roma, Rozzano
2025-06-26
Recruiting
Eli Lilly and Company
Phase 3
350
Bologna, Castellana Grotte, Milan, Padova, Pisa, Rho, Roma, Rozzano
2025-06-26
Recruiting
Bristol-Myers Squibb
Phase 3
274
Milan, Pisa, Siena, Ancona, Genova
2025-06-13
Recruiting
GlaxoSmithKline
Phase 1/2
451
Milan, Pisa, Roma
2025-06-11
Recruiting
A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD
NCT07038200Facioscapulohumeral Muscular Dystrophy, FSHD, FSHD - Facioscapulohumeral Muscular Dystrophy, FSHD1
DrugDel-brax
Avidity Biosciences, Inc.
Phase 3
200
Milan, Pisa, Roma
2025-06-10
Recruiting
SLIT ABS: Study on Patients With Autoimmune Podocytopathy
NCT07516964Nephrotic Syndrome With Edema (Diagnosis), Minimal Change Nephrotic Syndrome, Focal Segmental Glomerulosclerosis (FSGS), Nephrotic Syndrome Due to Idiopathic Membranous Nephropathy
Meyer Children's Hospital IRCCS
Not applicable
50
Bagno a Ripoli, Florence, Bologna, Genova, Parma, Pisa, Prato, Reggio Emilia
2025-06-10
Active, closed
Ionis Pharmaceuticals, Inc.
Phase 3
156
Milan, Pisa, Roma
2025-06-10
Recruiting
Regione del Veneto - AULSS n. 7 Pedemontana
Not applicable
430
Pisa, Santorso
2025-06-03
Recruiting
MediWound Ltd
Phase 3
216
Brindisi, Naples, Genoa, Pisa, Padova, Roma
2025-06-01
Recruiting
Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
NCT06784752Somatostatin Receptor Positive (SSTR+), Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
DrugOctreotide LAR
Novartis Pharmaceuticals
Phase 3
240
Cona, Genova, Milan, Rozzano, Pisa, Roma
2025-05-30
Recruiting
Sarcopenia in Gestational Diabetes
NCT06876090Sarcopenia, Gestational Diabetes Mellitus (GDM), Pregnancy Complications, Adverse Maternal and Neonatal Outcomes
Istituto di Neuroscienze Consiglio Nazionale delle Ricerche
Observational
200
Padova, Pisa
2025-05-28
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,123
Meldola, Milan, Catania, Florence, Naples, Pisa, Roma, Torino
2025-05-22
Recruiting
Boehringer Ingelheim
Phase 3
4,200
Bergamo, Naples, Pavia, Pisa, Roma, Rozzano
2025-05-20
Recruiting
Novartis Pharmaceuticals
Phase 2
224
Ancona, Cona, Pisa
2025-05-16
Recruiting
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
NCT06563895Amyloidosis, Amyloid Cardiomyopathy, Transthyretin Amyloidosis, Cardiomyopathies
DrugAcoramidis
Eidos Therapeutics, a BridgeBio company
Phase 3
587
Bologna, Florence, Pavia, Pisa, Roma, Rome
2025-05-12
Recruiting
Takeda
Phase 3
59
Milan, Rozzano, Orbassano, Brescia, Genova, Messina, Pavia, Pisa
2025-05-06
Recruiting
AstraZeneca
Phase 3
1,220
Bologna, Milan, Palermo, Perugia, Pisa, Roma, Rozzano
2025-05-06
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
NCT06881784NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer, NSCLC, NSCLC (Non-small Cell Lung Carcinoma)
DrugsCetuximab·Docetaxel
Revolution Medicines, Inc.
Phase 3
590
Milan, Rossano, Monza, Naples, Pisa, Roma, Rome
2025-05-06
Recruiting
Unmet Needs Among Patients With Isolated REM Sleep Behavior Disorder (iRBD) and Their Significant Others
NCT07498452REM Sleep Behavior Disorder, Isolated REM Sleep Behavior Disorder
Universita di Verona
Observational
150
Bologna, Genoa, Milan, Pavia, Cagliari, Troina, Pisa, Verona
2025-05-06
Recruiting
VitaFlow LIBERTY Europe
NCT06535659Aortic Valve Stenosis
Shanghai MicroPort CardioFlow Medtech Co., Ltd.
Observational
222
Castel Volturno, Pisa, Potenza
2025-05-06
By invitation
ESCAPE10: Epidemiology, Risk Factors, and Outcomes of Severe Community-acquired Pneumonia in Elderly Patients Acquired Pneumonia in Elderly Patients
NCT07070284Severe Community-Acquired Pneumonia (sCAP), Elderly Infection, Community-Acquired Infections, Health Care Quality, Access, and Evaluation
Joan Sabater-Riera
Observational
500
Modena, Rome, Gavardo, Palermo, Pisa
2025-05-01
Recruiting
AstraZeneca
Phase 3
830
Candiolo, Lecco, Lucca, Meldola, Milan, Naples, Peschiera del Garda, Pisa
2025-04-10
Recruiting
Merck Sharp & Dohme LLC
Phase 3
770
Aviano, Milan, Pisa, Bari, Brescia, Naples, Padova, Roma
2025-04-09
By invitation
Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP
NCT06859099Polyneuropathy, Inflammatory Demyelinating, Chronic
DrugRiliprubart
Sanofi
Phase 3
300
Genoa, Milan, Rozzano, Rome, Pavia, Pisa
2025-04-01
Not yet open
Certmedica International GmbH
Not applicable
240
Pisa, Chieti, Perugia
2025-04-01
Recruiting
Daiichi Sankyo
Phase 3
582
Bari, Bologna, Catania, Milan, Monza, Naples, Pisa, Ponderano
2025-03-19
Recruiting
Immunovant Sciences GmbH
Phase 2
162
Bergamo, Bologna, Brescia, Milan, Pavia, Pisa, Roma, Siena
2025-03-18
Recruiting
AstraZeneca
Phase 2
80
Bologna, Castelfranco Veneto, Florence, Milan, Naples, Pavia, Pisa, Roma
2025-03-12
Active, closed
Amgen
Phase 3
3,853
Bologna, Chieti, Florence, Milan, Palermo, Pisa, Roma
2025-03-12
Recruiting
Takeda
Phase 3
1,088
Torrette, Rome, Milan, Rozzano, Padova, Florence, Pisa
2025-03-03
Recruiting
Daiichi Sankyo
Phase 3
726
Catania, Florenze, Genova, Milan, Modena, Naples, Padova, Pisa
2025-02-27
Recruiting
Amgen
Phase 3
844
Udine, Rome, Milan, Turin, Verona, Pisa, Reggio Emilia
2025-02-25
Recruiting
LEO Pharma
Phase 3
90
Milan, Pisa, Roma, Rozzano (MI), Torino
2025-02-05
Recruiting
Azienda Ospedaliero, Universitaria Pisana
Observational
100
Pisa
2025-02-01
Active, closed
Novartis Pharmaceuticals
Phase 3
588
Ancona, Brescia, Catania, Cona, Florence, Rozzano, Modena, Pisa
2025-01-31
Active, closed
Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)
NCT06710132Solid Tumors, Gastric Cancer, Non-Small Cell Lung Cancer (NSCLC), Pancreatic Cancer
DrugM9140
EMD Serono Research & Development Institute, Inc.
Phase 1/2
184
Rome, Ancona, Milan, Naples, Padova, Pisa, Reggio Emilia, Roma
2025-01-29
Recruiting
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
NCT06680830Parkinson Disease, Parkinson, Idiopathic Parkinson Disease, Early Parkinson Disease (Early PD)
Neuron23 Inc.
Phase 2
150
Milan, Naples, Padua, Pisa, Rome
2025-01-17
Active, closed
argenx
Phase 3
631
Brescia, Pisa, Roma
2025-01-15
Recruiting
University of Pisa
Observational
90
Pisa
2025-01-01
Recruiting
Università Vita-Salute San Raffaele
Not applicable
600
Catania, Foggia, Milan, Pisa
2024-12-20
Recruiting
Immunovant Sciences GmbH
Phase 2
240
Bologna, Cagliari, Genova, Milan, Naples, Pisa, Roma, Siena
2024-12-17
Recruiting
GlaxoSmithKline
Phase 3
520
Ancona, Catania, Meldola FC, Palermo, Pavia, Pisa, Roma
2024-12-16
Recruiting
Janssen Research & Development, LLC
Phase 3
700
Candiolo, Catania, Florence, Milan, Padova, Pisa, Rozzano, Udine
2024-12-12
Recruiting
Basilea Pharmaceutica
Phase 3
450
Cuneo, Genoa, Milan, Modena, Pavia, Pisa, Siena, Trieste
2024-12-11
Active, closed
Sanofi
Phase 2
260
Milan, Rozzano, Padua, Rome, Pisa
2024-12-10
Active, closed
Janssen Research & Development, LLC
Phase 3
655
Milan, Palermo, Perugia, Pisa, Roma, Rozzano, Udine
2024-12-04
Recruiting
Meyer Children's Hospital IRCCS
Observational
138
Arezzo, Bagno a Ripoli, Florence, Pisa, Pistoia, Prato, Siena
2024-12-04
Active, closed
AstraZeneca
Phase 3
181
Bologna, Catania, Florence, Padua, Pisa, Roma, Rozzano
2024-12-03
Active, closed
H. Lundbeck A/S
Phase 3
401
Bologna, Milan, Naples, Pisa, Salerno
2024-12-03
Recruiting
Centro Medico Teknon
Observational
150
Rozzano, Pisa
2024-12-02
Recruiting
Novo Nordisk A/S
Phase 2
465
L’Aquila, Chieti, Bologna, Bergamo, Brescia, Milan, Pisa, Roma
2024-12-02
Recruiting
Merck Sharp & Dohme LLC
Phase 3
3,082
Bologna, Genova, Milan, Pisa
2024-12-02
Recruiting
UCB Biopharma SRL
Phase 3
450
Brescia, Genova, Milan, Padova, Pisa, Roma, Rozzano
2024-11-21
Active, closed
GlaxoSmithKline
Phase 2
283
Bergamo, Florence, Milan, Naples, Padova, Pisa, Roma
2024-11-11
Recruiting
argenx
Observational
680
Bergamo, Bologna, Naples, Pisa, Roma
2024-11-04
Recruiting
Telehealth Intervention for Infants With Prodromes of ASD
NCT06817746Autism Spectrum Disorder (ASD)
IRCCS Fondazione Stella Maris
Not applicable
132
Pisa, Rovereto, Messina
2024-11-01
Active, closed
Novartis Pharmaceuticals
Phase 2
96
Ancona, Bergamo, Brescia, Genova, Milan, Pescara, Perugia, Pisa
2024-10-29
Recruiting
Société des Produits Nestlé (SPN)
Not applicable
104
Naples, Parma, Pisa, Rome, Turin
2024-10-25
Recruiting
Gelsectan® in the Treatment of Patients With Diarrhoea-predominant Irritable Bowel Syndrome
NCT06681012Irritable Bowel Syndrome (IBS), Irritable Bowel Syndrome of Diarrhea Type (IBS-D)
Devintec Sagl
Not applicable
330
Bologna, Milan, Naples, Padova, Pavia, Pisa, Roma
2024-10-22
Recruiting
Janssen Research & Development, LLC
Phase 3
1,000
Meldola, Milan, Padova, Pisa, Rozzano
2024-10-18
Active, closed
Novartis Pharmaceuticals
Phase 2
251
Milan, Modena, Pisa, Torino
2024-10-17
Active, closed
Revolution Medicines, Inc.
Phase 3
500
Milan, Padova, Pisa
2024-10-16
Recruiting
North Eastern German Society of Gynaecological Oncology
Phase 2
640
Bologna, Brescia, Lecco, Milan, Monserrato, Padova, Pisa, Reggio Emilia
2024-10-11
Active, closed
Incyte Corporation
Phase 3
349
Catania, Chieti, L’Aquila, Milan, Naples, Perugia, Pisa, Rome
2024-10-10
Recruiting
Primary Cardiac Lymphoma: Italian Multicenter Experience
NCT05819528Primary Cardiac Lymphoma
Fondazione Italiana Linfomi - ETS
Observational
43
Bergamo, Brescia, Ferrara, Milan, Perugia, Pisa, Roma, Sassari
2024-10-02
By invitation
Open-Label Extension Study to Assess GLM101 in PMM2-CDG Patients
NCT06657859Pmm2-CDG, Phosphomannomutase 2 Deficiency
Glycomine, Inc.
Phase 2
90
Catania, Pisa
2024-09-30
Active, closed
Hoffmann-La Roche
Phase 3
338
Bari, Parma, Rome, Genoa, Sassari, Florence, Pisa, Padova
2024-09-23
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
160
Meldola, Milan, Pisa
2024-09-20
Active, closed
Regeneron Pharmaceuticals
Phase 2
151
Cuneo, Ferrara, Milan, Naples, Novara, Pisa, Rome, Taormina
2024-09-18
Active, closed
Zenas BioPharma (USA), LLC
Phase 2
190
Ferrara, Genova, Milan, Pisa, Roma, Torino, Verona
2024-09-17
Recruiting
GlaxoSmithKline
Phase 3
440
Ancona, Milan, Modena, Naples, Padova, Palermo, Pavia, Pisa
2024-09-11
Active, closed
Novartis Pharmaceuticals
Phase 2
179
Alessandria, Ancona, Genova, Milan, Rozzano, Pescara, Pisa, Pavia
2024-09-04
Active, closed
Servier Bio-Innovation LLC
Phase 1/2
48
Campania, Milan, Pisa, Rome, Verona
2024-08-31
Active, closed
Sanofi
Phase 2
229
Milan, Padua, Pisa
2024-08-29
Active, closed
Gilead Sciences
Phase 3
640
Aviano, Florence, Lecco, Meldola, Milan, Padova, Pisa, Roma
2024-08-28
Recruiting
Abbott Structural Heart Device Registry
NCT06590467Heart Diseases, ASD - Atrial Septal Defect, VSD - Muscular Ventricular Septal Defect, PFO - Patent Foramen Ovale
Abbott Medical Devices
Observational
2,500
San Donato Milanese, Turin, Pisa
2024-08-21
Active, closed
argenx
Phase 2
3
Pisa, Rome
2024-08-20
Recruiting
Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)
NCT06445972Gastroesophageal Junction, Gastroesophageal Adenocarcinoma, Esophageal Neoplasms, Esophageal Cancer
DrugsPatritumab deruxtecan·Ramucirumab·Sacituzumab tirumotecan·Paclitaxel
Merck Sharp & Dohme LLC
Phase 1/2
210
Meldola, Milan, Pisa
2024-08-07
Recruiting
Janssen Research & Development, LLC
Phase 3
752
Brescia, Catania, Chieti, Genova, Monza, Pisa, Roma, Salerno
2024-07-25
Active, closed
Gruppo Oncologico del Nord-Ovest
Phase 2
16
Monserrato, Meldola, San Giovanni Rotondo, Tricase, Milan, Padova, Pisa, Prato
2024-07-23
Active, closed
Ferrer Internacional S.A.
Phase 2
241
Bologna, Padova, Pisa, Roma, Salerno
2024-07-23
Recruiting
IRCCS Fondazione Stella Maris
Observational
50
Pisa
2024-07-19
Recruiting
Jazz Pharmaceuticals
Phase 3
286
Monserrato, Candiolo, Genova, Milan, Naples, Padova, Pisa, Roma
2024-07-19
Recruiting
Azienda USL Reggio Emilia - IRCCS
Not applicable
100
Pisa, Spilamberto
2024-07-17
Recruiting
Heidelberg University
Observational
4,000
Calambrone, Conegliano, Pisa, Roma
2024-07-16
Active, closed
A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work
NCT06290128Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Polyneuropathy, Inflammatory Demyelinating, Chronic
DrugRiliprubart
Sanofi
Phase 3
109
Milan, Rozzano, Rome, Messina, Palermo, Pavia, Pisa
2024-07-12
Active, closed
Amgen
Phase 3
89
Naples, Pisa
2024-07-05
Active, closed
UCB Biopharma SRL
Phase 3
176
Ancona, Località Torrette, Catania, Pisa, Roma
2024-06-25
Recruiting
AstraZeneca
Phase 3
240
Ancona, Bari, Catania, Milan, Padova, Palermo, Pavia, Pisa
2024-06-20
Recruiting
H. Lundbeck A/S
Phase 2
18
Padova, Pisa, Messina, Rome, Torino
2024-06-19
Active, closed
Janssen Research & Development, LLC
Phase 1
108
Ancona, Bergamo, Brescia, Meldola, Pisa, Rome
2024-06-07
Active, closed
GlaxoSmithKline
Phase 4
303
Brescia, Ferrara, Milan, Pisa, Reggio Emilia, Rome, Rozzano
2024-06-06
Recruiting
Spinocerebellar Ataxia Type 27B Natural History Study (SCA27B-NHS)
NCT06472557Spinocerebellar Ataxia Type 27B
University Hospital Tuebingen
Observational
300
Pisa
2024-06-04
Active, closed
Amgen
Phase 1/2
94
Milan, Pisa, Varese
2024-05-30
Active, closed
ELVN-002 With Trastuzumab +/- Chemotherapy in HER2+ Solid Tumors, Colorectal and Breast Cancer
NCT06328738HER2-positive Breast Cancer, HER2-positive Gastric Cancer, HER2 Positive Solid Tumors, HER2 Amplification
DrugsELVN-002·Eribulin·Leucovorin·Trastuzumab
Enliven Therapeutics
Phase 1
275
Catanzaro, Milan, Monza, Pisa, Reggio Emilia, Rome
2024-05-30
Recruiting
University Hospital, Antwerp
Phase 3
174
Milan, Arezzo, Bergamo, Brescia, Florence, Lecco, Pavia, Pisa
2024-05-24
Recruiting
Novartis Pharmaceuticals
Phase 3
550
Cona, Pisa, Roma, Torino
2024-05-21
Recruiting
NMD Pharma A/S
Phase 2
84
Bergamo, Bologna, Genova, Milan, Naples, Pisa, Roma
2024-05-16
Active, closed
Sanofi
Phase 3
1,541
Milan, Rozzano, Rome, Bologna, Catania, L’Aquila, Pisa, Vicenza
2024-05-08
Active, closed
Merck Sharp & Dohme LLC
Phase 3
450
Naples, Rome, Milan, Pisa
2024-05-03
Active, closed
Azienda Ospedaliero, Universitaria Pisana
Observational
1,000
Bari, Catania, Pisa
2024-05-01
Not yet open
TRAnscutaneous vaGUS Nerve Stimulation in Patients With Chronic Heart Failure
NCT06355388Heart Failure, Heart Failure With Reduced Ejection Fraction, Heart Failure With Midrange Ejection Fraction
Fondazione Toscana Gabriele Monasterio
Not applicable
24
Pisa
2024-05-01
Active, closed
Eli Lilly and Company
Phase 3
10,000
Bologna, Ferrara, Genova, Milan, Palermo, Perugia, Pisa, Roma
2024-04-30
Recruiting
Francesco De Cobelli
Phase 2
33
Bergamo, Milan, Naples, Pisa
2024-04-30
Recruiting
Eli Lilly and Company
Phase 3
510
Florence, Milan, Naples, Padova, Pisa, Rome, Vimercate
2024-04-29
Recruiting
University of Pisa
Observational
40
Pisa
2024-04-02
Recruiting
ASST Ovest Milanese
Not applicable
140
Monfalcone, Abbiategrasso, Abano Terme, Arezzo, Forlì, Lucca, Pisa
2024-03-21
Recruiting
Effect of Oral sucRosomIal Iron on exerciSE Capacity and Quality of Life in Patients With Heart Failure
NCT06270498Chronic Heart Failure, Iron-deficiency, Left Ventricular Systolic Dysfunction
Raffaele De Caterina
Phase 4
60
Pisa
2024-03-14
Recruiting
Novartis Pharmaceuticals
Phase 3
450
Brescia, Cona, Genova, Milan, Rozzano, Pisa, Roma, Negrar
2024-03-12
Active, closed
AstraZeneca
Phase 3
594
Florence, Milan, Naples, Padova, Pisa, Vicenza
2024-03-04
By invitation
Sarepta Therapeutics, Inc.
Phase 1/2
78
Gussago, Milan, Pisa, Roma
2024-03-04
Recruiting
Azienda Ospedaliero, Universitaria Pisana
Not applicable
100
Pisa
2024-03-04
Not yet open
IRCCS Fondazione Stella Maris
Not applicable
40
Pisa
2024-03-01
Recruiting
medac GmbH
Phase 3
277
Arezzo, Ferrara, Florence, Naples, Parma, Pisa
2024-02-27
Active, closed
Dianthus Therapeutics
Phase 2
65
Milan, Naples, Pisa, Rome
2024-02-23
Active, closed
Novo Nordisk A/S
Phase 2
80
Pisa, Pavia
2024-02-20
Active, closed
Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC)
NCT06117774Limited Stage Small Cell Lung Cancer, Small Cell Lung Cancer
DrugTarlatamab
Amgen
Phase 3
404
Aviano PN, Milan, Orbassano, Padova, Perugia, Pisa, Reggio Emilia, Rozzano MI
2024-02-20
Active, closed
Tourmaline Bio, Inc., a Novartis Company
Phase 2
79
Naples, Pisa
2024-02-19
Recruiting
Pfizer
Phase 3
492
Milan, Legnano, Turin, Palermo, Ancona, Florence, Pisa, Bologna
2024-02-08
Recruiting
Amryt Pharma
Phase 4
12
Bologna, Catanzaro, Novara, Pisa, Udine
2024-02-08
By invitation
University of Pisa
Observational
50
Pisa
2024-02-01
Active, closed
Astellas Gene Therapies
Not applicable
119
Florence, Gussago, Messina, Milan, Pavia, Pisa, Roma, Udine
2024-02-01
Active, closed
Incyte Corporation
Phase 3
617
Ancona, Catania, Milan, Pisa, Roma, Rozzano
2024-01-30
Recruiting
Genexine, Inc.
Phase 3
429
Brescia, Florence, Foggia, Genova, Pavia, Pisa, Verona
2024-01-25
Recruiting
IRCCS Fondazione Stella Maris
Observational
500
Pisa
2024-01-24
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 3
124
Florence, Milan, Padova, Pisa, San Giovanni Rotondo, Verona
2024-01-03
Recruiting
University of Pisa
Observational
80
Pisa
2024-01-01
Not yet open
University of Pisa
Phase 3
102
Pisa
2024-01-01
Active, closed
Merck Sharp & Dohme LLC
Phase 3
340
Cona, Meldola, Milan, Florence, Pisa, Castelfranco Veneto, Alessandria, Ancona
2023-12-31
Recruiting
Federico II University
Not applicable
100
Naples, Novara, Pisa, Roma
2023-12-29
Recruiting
Bristol-Myers Squibb
Phase 1/2
460
Bologna, Brescia, Milan, Pisa, Ravenna, Roma, Verona
2023-12-29
Recruiting
Observational Study Protocol: LIVER-R
NCT06252753Hepatobiliary Cancers
AstraZeneca
Observational
4,000
Naples, Rome, Brescia, Milan, Rozzano, Turin, Monserrato, Pisa
2023-12-20
Active, closed
TransThera Sciences (Nanjing), Inc.
Phase 3
200
Ancona, Candiolo, Meldola, Milan, Naples, Parma, Pisa, Rozzano
2023-12-20
Recruiting
Intellia Therapeutics
Phase 3
1,200
Bologna, Cona, Florence, Genova, Pavia, Pisa, Trieste
2023-12-13
Active, closed
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
257
Castellana Grotte, Catania, Florence, Genova, Milan, Modena, Naples, Pisa
2023-12-05
Recruiting
University of Pisa
Observational
5,000
Pisa
2023-12-05
Active, closed
AstraZeneca
Phase 3
760
Florence, Milan, Padova, Pisa, Rozzano, Tricase, Lecce
2023-12-04
Active, closed
argenx
Observational
413
Florence, Gussago, Messina, Novara, Orbassano, Palermo, Pavia, Pisa
2023-11-29
Recruiting
Laboratory Biomarkers and Pulmonary Interstitial Emphysema in ARDS (PIE-ARDS)
NCT06001645Acute Respiratory Distress Syndrome, Barotrauma
Università Vita-Salute San Raffaele
Observational
110
Cagliari, Milan, Pisa, Potenza
2023-11-27
Recruiting
Predictors of Emergency Department Use in Frail Patients
NCT07259499Alzheimer s Disease, Vascular Dementia, Frailty, Elderly
University of Pisa
Observational
110
Pisa
2023-11-19
Active, closed
Regeneron Pharmaceuticals
Phase 3
733
Meldola, Turin, Palermo, Milan, Modena, Naples, Perugia, Pisa
2023-11-14
Active, closed
AstraZeneca
Phase 3
1,835
Bergamo, Bologna, Foggia, Genoa, Naples, Pisa, Roma, Torino
2023-11-07
Active, closed
Bristol-Myers Squibb
Phase 2
227
Naples, San Donato Milanese, Pisa, Bergamo
2023-11-07
Active, closed
Bristol-Myers Squibb
Phase 3
1,057
Ancona, Modena, Florence, Milan, Pisa, Roma, Trieste, Bergamo
2023-10-25
Not yet open
IRCCS Fondazione Stella Maris
Observational
500
Pisa
2023-10-10
Recruiting
dr. M.J.N.L. Benders
Observational
1,000
Florence, Genova, Milan, Pisa
2023-10-06
Recruiting
Centre Hospitalier Universitaire de Nice
Not applicable
50
Rome, Milan, Pisa
2023-10-03
Active, closed
Tensive SRL
Not applicable
92
Rozzano, Catania, Milan, Pavia, Pisa, Roma, Torino
2023-09-29
Recruiting
Identification of the Pathogenetic Mechanisms Underlying Squamous Cell Carcinomas
NCT06236464Squamous Cell Carcinoma of the Head and Neck, Squamous Cell Carcinoma of the Anus
National Cancer Institute, Naples
Observational
170
Bari, Naples, Novara, Pisa
2023-09-25
Active, closed
Bristol-Myers Squibb
Phase 3
1,255
Bologna, Modena, Florence, Milan, Pisa, Roma, Ancona, Bergamo
2023-09-14
By invitation
argenx
Phase 3
240
Bari, Milan, Pisa, Roma, Rozzano, Udine
2023-09-12
Active, closed
Bristol-Myers Squibb
Phase 3
774
Brescia, Milan, Naples, Pisa, Rome, Udine
2023-09-11
Recruiting
Gilead Sciences
Phase 3
402
Ancona, Castellana Grotte, Milan, Modena, Monza, Padova, Palermo, Pisa
2023-09-07
Recruiting
The ReTAVI Prospective Observational Registry
NCT05601453Structural Valve Deterioration, Structural Valve Degeneration, Symptomatic Patients Who Have Had Transcatheter Heart Valve (THV) Failure, Prosthetic Valve Malfunction
Institut für Pharmakologie und Präventive Medizin
Observational
250
Ancona, Bologna, Brescia, Florence, Milan, Padua, Pisa, Roma
2023-09-05
Recruiting
Ipsen
Phase 3
276
Modena, Monza, Naples, Padova, Palermo, Pavia, Pisa, San Giovanni Rotondo
2023-08-31
Active, closed
Cytokinetics
Phase 3
500
San Donato Milanese, Brescia, Florence, Foggia, Milan, Naples, Pisa, Roma
2023-08-31
Active, closed
Teva Branded Pharmaceutical Products R&D LLC
Phase 3
2,772
Ferrara, Padova, Pisa, Verona
2023-08-30
Active, closed
AstraZeneca
Phase 3
142
Castelfranco Veneto, Foggia, Palermo, Pisa, Rozzano
2023-08-16
Recruiting
Ponatinib in Chronic Myeloid Leukemia Patients in Chronic Phase
NCT06119269Chronic Myeloid Leukemia, Chronic Phase
University of Pisa
Observational
100
Cagliari, Milan, Naples, Pisa, Roma
2023-08-02
Recruiting
GlaxoSmithKline
Phase 3
892
Cagliari, Genova, Milan, Naples, Padova, Pisa, Reggio Emilia, Roma
2023-08-01
Active, closed
AbbVie
Phase 3
1,014
Rome, Ancona, Padova, Pisa
2023-07-25
Recruiting
Lung cAncer Robotic Comparative Study
NCT06038227Lung Cancer
Intuitive Surgical
Observational
600
Pisa
2023-07-15
Active, closed
Mineralys Therapeutics Inc.
Phase 3
1,076
Bologna, Ferrara, Genova, Messina, Pisa, Roma
2023-07-14
Recruiting
Meyer Children's Hospital IRCCS
Not applicable
340
Florence, Pisa, Siena
2023-07-05
Active, closed
AstraZeneca
Phase 3
111
Milan, Naples, Padova, Pisa, Rozzano, Turin
2023-06-27
Active, closed
Bristol-Myers Squibb
Phase 3
1,230
Catania, Florence, Genova, Milan, Pisa, Roma, Torino, Naples
2023-06-22
Active, closed
AbbVie
Phase 3
1,328
Cona, Florence, L’Aquila, Rome, Brescia, Milan, Modena, Pisa
2023-06-21
Active, closed
Alfasigma S.p.A.
Observational
509
Bari, Milan, Pisa, Negrar, Palermo, Rozzano, Torino
2023-06-12
Recruiting
H. Lundbeck A/S
Phase 3
315
Cagliari, Genoa, Milan, Pavia, Pisa, Rome
2023-06-08
Active, closed
Evaluation of the Safety and Efficacy of Eneboparatide (AZP-3601) in Patients With Chronic Hypoparathyroidism
NCT05778071Chronic Hypoparathyroidism, Endocrine System Diseases, Parathyroid Diseases
Alexion Pharmaceuticals, Inc.
Phase 3
165
Bologna, Florence, Milan, Pisa, Roma
2023-06-07
Recruiting
University of Pisa
Observational
300
Pisa
2023-05-25
By invitation
Azienda Ospedaliero, Universitaria Pisana
Observational
130
Pisa
2023-05-17
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
230
Meldola, Milan, Pisa, Padova
2023-05-16
Active, closed
A Study to Learn How Well Dupilumab Works in Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis and the Side Effects it May Have
NCT05831176Eosinophilic Gastritis (EoG), Eosinophilic Duodenitis (EoD), Eosinophilic Gastrointestinal Disease (EGID), Eosinophilic Gastroenteritis
DrugDupilumab
Regeneron Pharmaceuticals
Phase 2
22
Rozzano, Palermo, Bari, Milan, Pisa, Roma, Rome
2023-05-03
By invitation
An Open-label Study of XEN1101 in Epilepsy
NCT05718817Focal Epilepsy, Tonic-Clonic Seizures
DrugAzetukalner
Xenon Pharmaceuticals Inc.
Phase 3
880
Bologna, Chieti, Pisa, Roma
2023-04-25
Active, closed
Novartis Pharmaceuticals
Phase 3
288
Ancona, Cona, Padova, Pisa, Roma, Torino
2023-04-21
Active, closed
Karyopharm Therapeutics Inc
Phase 3
257
Bologna, Brescia, Meldola, Milan, Monza, Naples, Padova, Pisa
2023-04-18
Recruiting
Eli Lilly and Company
Phase 1/2
880
Alessandria, Brescia, Milan, Monza, Pisa, Ravenna, Roma, Verona
2023-04-17
Recruiting
Iovance Biotherapeutics, Inc.
Phase 3
670
Meldola, Aviano, Naples, Pisa, Milan, Siena
2023-03-30
Active, closed
Janssen Research & Development, LLC
Phase 3
614
Bologna, Milan, Palermo, Pisa, Reggio Emilia, Roma, Siena, Turin
2023-03-29
Recruiting
Azienda Ospedaliero, Universitaria Pisana
Not applicable
100
Pisa
2023-03-29
Active, closed
Pfizer
Phase 3
624
Naples, Misterbianco, Bologna, Cona, Rome, Monza, Ancona, Pisa
2023-03-03
Recruiting
Xenon Pharmaceuticals Inc.
Phase 3
160
Ancona, Chieti, Pisa, Roma
2023-02-14
Recruiting
Medtronic Cardiovascular
Not applicable
400
Bologna, Brescia, Milan, Pisa, San Donato Milanese
2023-02-07
Active, closed
argenx
Phase 2
51
Milan, Pisa, Rome, Rozzano
2023-01-18
Active, closed
Bristol-Myers Squibb
Phase 3
516
Rome, Milan, Pisa, Padova, Brescia, Naples, Verona
2023-01-12
Active, closed
Bristol-Myers Squibb
Phase 3
606
Meldola, Milan, Rozzano, Bologna, Catanzaro, Lecce, Pisa, Udine
2023-01-10
Active, closed
Calcilytix Therapeutics, Inc., a BridgeBio company
Phase 3
67
Milan, Pisa, Roma
2023-01-06
Active, closed
AriBio Co., Ltd.
Phase 3
1,535
Ancona, Brescia, Milan, Monza, Pisa, Roma, Torino, Tricase
2022-12-23
Recruiting
Pharming Technologies B.V.
Phase 2
180
Bologna, Messina, Milan, Pisa, Roma
2022-12-13
By invitation
Ionis Pharmaceuticals, Inc.
Phase 3
1,400
Ancona, Florence, Padova, Pavia, Pisa, Roma
2022-11-30
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 3
260
Bergamo, Brescia, Florence, Milan, Naples, Palermo, Pisa, Roma
2022-11-21
Active, closed
Novartis Pharmaceuticals
Phase 3
568
Meldola, Milan, Pisa, Roma, Torino
2022-11-21
Active, closed
AstraZeneca
Phase 3
368
Bologna, Milan, Naples, Padova, Pisa, Roma, Rozzano, Verona
2022-11-10
Recruiting
Regeneron Pharmaceuticals
Observational
500
Misterbianco, Florence, Udine, Rozzano, Orbassano, Pisa, Catania, Milan
2022-10-26
Active, closed
Hoffmann-La Roche
Phase 1
121
Bologna, Meldola, Milan, Pisa
2022-10-26
Active, closed
GlaxoSmithKline
Phase 2
351
Avellino, Bergamo, Genova, Pisa, Verona
2022-10-14
Active, closed
A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease
NCT05347095Fistulizing Crohns Disease, Perianal Crohns Disease
DrugGuselkumab
Janssen-Cilag Ltd.
Phase 3
288
Milan, Negrar ( Ve), Pisa, Rho, Roma, Rozzano, San Giovanni Rotondo
2022-09-27
Active, closed
Vir Biotechnology, Inc.
Phase 2
95
Milan, Pisa
2022-09-17
Active, closed
Madrigal Pharmaceuticals, Inc.
Phase 3
845
San Giovanni Rotondo, Milan, Rozzano, Roma, Torino, Florence, Palermo, Pisa
2022-08-26
Recruiting
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
410
Salerno, Rome, Baggiovara, Ponderano (Biella), Florence, Milan, Monza, Pisa
2022-08-23
Active, closed
EMD Serono Research & Development Institute, Inc.
Phase 2
256
Bologna, Florence, Forlì, Milan, Misterbianco, Naples, Padova, Pisa
2022-08-17
Active, closed
AbbVie
Observational
785
Castellana Grotte, Rozzano, Milan, Naples, Rome, Negrar, Palermo, Pisa
2022-08-15
Recruiting
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
NCT05254171Pancreatic Cancer Metastatic, Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer Stage IV
DrugsAbraxane·Nab-paclitaxel·Gemcitabine
Panbela Therapeutics, Inc.
Phase 2/3
600
San Giovanni Rotondo, Meldola, Reggio Emilia, Milan, Candiolo, Pisa, Terni, Verona
2022-08-08
Active, closed
Eli Lilly and Company
Phase 4
780
Bari, Naples, Milan, Moncalieri, Olbia, Palermo, Pisa, Catanzaro
2022-08-01
Recruiting
Janssen Research & Development, LLC
Phase 1/2
225
Milan, Pisa
2022-07-29
Active, closed
Incyte Corporation
Phase 1/2
53
Ravenna, Milan, Pavia, Monza, Candiolo, Pisa, Perugia
2022-07-19
Active, closed
Regeneron Pharmaceuticals
Phase 3
1,546
Naples, San Giovanni Rotondo, Genoa, Rozzano, Candiolo, Pisa, Bari, Brescia
2022-07-14
Active, closed
GlaxoSmithKline
Phase 3
163
Bari, Brescia, Florence, Milan, Pavia, Pisa, Roma, Torrette AN
2022-07-14
Active, closed
Pfizer
Phase 2
108
Monserrato, Naples, Guastalla, San Giovanni Rotondo, Milan, Candiolo, Livorno, Pisa
2022-07-11
Active, closed
Celgene
Phase 3
939
Rome, Bologna, Catania, Genova, Milan, Novara, Pavia, Pisa
2022-06-23
Recruiting
Istituto Ortopedico Rizzoli
Observational
150
Bologna, Pisa
2022-06-13
Recruiting
Pirfenidone to Prevent Fibrosis in Ards.
NCT05075161Acute Respiratory Distress Syndrome (ARDS)
DrugPirfenidone
Università Vita-Salute San Raffaele
Phase 3
130
Milan, Alessandria, Bari, Brescia, Cagliari, Merano, Palermo, Pisa
2022-06-01
Active, closed
Chlorhexidine Plus Hyaluronic Acid Mouthwash in Surgical Wound Healing Following Third Molar Surgery
NCT05414253Wound Heal, Surgical Wound, Impacted Third Molar Tooth
University of Pisa
Not applicable
54
Pisa
2022-06-01
Recruiting
Seagen, a wholly owned subsidiary of Pfizer
Phase 2
372
Milan, Aviano, Roma, Padova, Pisa, Terni
2022-05-03
By invitation
AstraZeneca
Phase 3
214
Arezzo, Bari, Catania, Meldola, Milan, Modena, Padova, Pisa
2022-04-19
Active, closed
Olorofim Aspergillus Infection Study
NCT05101187Invasive Aspergillosis
DrugAmbisome
F2G Biotech GmbH
Phase 3
225
Naples, Monza, Rozzano, Genova, Milan, Modena, Perugia, Pisa
2022-03-31
Recruiting
IRCCS Fondazione Stella Maris
Not applicable
115
Pisa
2022-02-01
Active, closed
Gruppo Oncologico del Nord-Ovest
Phase 1/2
48
Milan, Pisa
2022-01-25
Active, closed
Gruppo Oncologico del Nord-Ovest
Phase 2
63
Pisa
2022-01-25
Active, closed
University of Pisa
Not applicable
40
Pisa
2022-01-10
Recruiting
Advanced TecHnologies For SuccEssful AblatioN of AF in Clinical Practice
NCT05617456Cardiac Arrhythmia, Atrial Fibrillation
Giulio Zucchelli
Observational
4,100
Pisa
2022-01-01
Active, closed
Ionis Pharmaceuticals, Inc.
Phase 1/2
71
Pisa
2021-12-22
Active, closed
Regeneron Pharmaceuticals
Phase 3
288
Rome, Milan, Pisa, Bergamo, Roma
2021-12-14
Active, closed
GlaxoSmithKline
Phase 2
360
Bergamo, Milan, Modena, Naples, Palermo, Pisa
2021-12-14
Recruiting
RFC1 Natural History Study
NCT05177809Ataxia
Prof. Dr. Matthis Synofzik
Observational
150
Naples, Pisa
2021-12-14
Recruiting
H. Lundbeck A/S
Phase 3
600
Rome, Genoa, Milan, Cagliari, Florence, Pisa, Pavia
2021-12-01
Active, closed
Vorbipiprant (CR6086) / Balstilimab (AGEN2034) Combination in Stage IV Refractory pMMR - MSS CRC, and Other Metastatic GI Cancers
NCT05205330Refractory Metastatic Colorectal Cancer, Solid Tumor, Metastatic Microsatellite-stable Colorectal Cancer, Mismatch Repair Protein Proficient
DrugsVorbipiprant·Balstilimab
Rottapharm Biotech
Phase 1/2
107
Milan, Padova, Pisa
2021-11-23
Active, closed
Open-Label Safety Study of Acoramidis (AG10) in Symptomatic ATTR Participants
NCT04988386Amyloid Cardiomyopathy, Transthyretin-Related
DrugAcoramidis
Eidos Therapeutics, a BridgeBio company
Phase 3
389
Arezzo, Florence, Pisa, Pavia
2021-10-27
Active, closed
Hoffmann-La Roche
Phase 3
303
Rome, Milan, Pisa, Cona (Ferrara), Padova
2021-10-26
Active, closed
Mirum Pharmaceuticals, Inc.
Phase 2
333
Ancona, Bergamo, Milan, Modena, Monza, Padova, Palermo, Pisa
2021-09-22
Recruiting
Predictive BioMArkers of AlTERed NeurologicAL Trajectories Consequent to PrenataL InflammatorY Insults
NCT06852703Biomarkers, Neurodevelopmental Disorders, Inflammation, Brain
Istituto Clinico Humanitas
Observational
300
Pisa
2021-09-01
Active, closed
Janssen Pharmaceutica N.V., Belgium
Observational
1,314
Bari, Campobasso, Catanzaro, Florence, Naples, Palermo, Pisa, Potenza
2021-08-25
Active, closed
STOP Persistent AF PAS
NCT05005949Persistent Atrial Fibrillation
Medtronic Cardiac Ablation Solutions
Observational
400
Pisa
2021-08-19
Active, closed
Regeneron Pharmaceuticals
Observational
717
Rozzano, Catania, Pisa, Siena, Padova, Catanzaro, Genova, Rome
2021-08-12
Active, closed
Boston Scientific Corporation
Not applicable
297
Brescia, Cotignola, Naples, Pisa
2021-07-20
Active, closed
Biogen
Phase 3
562
Rozzano, Scafati, Brescia, Padova, Pisa, Roma
2021-07-16
Active, closed
A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases
NCT04554914Epstein-Barr Virus (EBV)-Associated Diseases, EBV+ Lymphoproliferative Disease With Primary Immunodeficiency (EBV+ PID LPD), EBV+ Lymphoproliferative Disease With Acquired (Non-congenital) Immunodeficiency (EBV+ AID LPD), EBV+ Posttransplant Lymphoproliferative Disease in Central Nervous System (EBV+ CNS PTLD)
DrugTabelecleucel
Pierre Fabre Medicament
Phase 2
190
Pisa, Roma, Torino
2021-07-14
Recruiting
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 3
434
Bologna, Meldola, Milan, Pisa, Verona
2021-07-06
Active, closed
Alveolar Ridge Preservation With Cortico-cancellous Porcine Bone
NCT06970184Alveolar Ridge Preservation, Implant Therapy, Tooth Extraction Site Healing
University of Pisa
Observational
22
Pisa
2021-06-15
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
520
Bologna, Milan, Pisa, Roma
2021-06-15
Active, closed
Daiichi Sankyo
Phase 3
490
Barone, Candiolo, Catanzaro, Milan, Modena, Naples, Padua, Pisa
2021-05-21
By invitation
Cytokinetics
Phase 2/3
900
Florence, Milan, Naples, Pisa, Roma, Trieste
2021-05-06
Active, closed
Abbott Medical Devices
Observational
200
Ancona, Brescia, Pisa
2021-05-04
Recruiting
RECORDATI GROUP
Phase 2
12
Pisa, Roma
2021-04-28
Active, closed
Hoffmann-La Roche
Phase 3
557
Naples, Bologna, Rome, Milan, Turin, Palermo, Florence, Pisa
2021-04-26
Recruiting
Tendyne European Experience Registry
NCT04898335Mitral Regurgitation
LMU Klinikum
Observational
400
Milan, Pisa
2021-04-15
Active, closed
SMall Annuli Randomized To Evolut™ or SAPIEN™ Trial
NCT04722250Symptomatic Aortic Stenosis, Aortic Valve Stenosis, Aortic Valve Replacement
Medtronic Cardiovascular
Not applicable
1,103
Bologna, Pisa, Verona
2021-04-02
Active, closed
Loxo Oncology, Inc.
Phase 3
238
Viale Orazio Flacco, Monza (MB) -Settore E, Pisa, Rionero in Vulture, Vicenza, Alessandria, Bergamo, Brescia
2021-03-09
Recruiting
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 1/2
27
Milan, Padova, Pisa
2021-01-01
Active, closed
Janssen Research & Development, LLC
Phase 2
220
Bari, Florence, Genova, Milan, Pisa, Roma, Rome, Torino
2020-12-18
Active, closed
ACURATE neo2™ Post Market Clinical Follow up Study
NCT04655248Aortic Valve Stenosis, Aortic Valve Calcification, Aortic Diseases
Boston Scientific Corporation
Observational
250
Catania, Milan, Pisa
2020-12-16
Active, closed
Amgen
Phase 3
135
Florence, Milan, Pisa, Reggio Emilia, Torino, Verona
2020-12-04
Active, closed
Dental Trauma - Avulsion
NCT07334405Dental Trauma
University of Pisa
Observational
13
Pisa
2020-11-20
Recruiting
CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registry
NCT04688190Mitral Regurgitation, Mitral Valve Disease, Mitral Annular Calcification
Universitätsklinikum Hamburg-Eppendorf
Observational
1,000
Brescia, Milan, Pisa
2020-11-01
Recruiting
IFOM ETS - The AIRC Institute of Molecular Oncology
Observational
500
Genova, Milan, Padua, Pisa, Candiolo, Orbassano, Torino
2020-10-28
Active, closed
CHAMPION-AF Clinical Trial
NCT04394546Atrial Fibrillation, Stroke, Bleeding
DrugsNon-Vitamin K Anticoagulant·NOAC
Boston Scientific Corporation
Not applicable
3,000
Pisa, Florence, Rivoli, Rozzano
2020-10-15
Active, closed
A Gene Transfer Study for Late-Onset Pompe Disease (RESOLUTE)
NCT04093349Pompe Disease, Pompe Disease (Late-onset), Glycogen Storage Disease Type 2, Glycogen Storage Disease Type II
Spark Therapeutics, Inc.
Phase 1/2
4
Messina, Milan, Naples, Pisa, Torino
2020-10-01
Active, closed
argenx
Phase 2
229
Brescia, Florence, Genova, Messina, Milan, Pisa, Roma, Torino
2020-09-18
Recruiting
BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours
NCT04421820Colorectal Cancer, Pancreatic Cancer, Gastric Cancers, Cholangiocarcinoma
DrugsBOLD-100·Oxaliplatin
Bold Therapeutics, Inc.
Phase 1/2
220
Milan, Naples, Pisa
2020-08-28
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 3
125
Naples, Pavia, Pisa, Roma
2020-08-25
Active, closed
Incyte Corporation
Phase 2
112
Bologna, Florence, Meldola (FC), Milan, Naples, Novara, Palermo, Pisa
2020-08-03
Active, closed
Genentech, Inc.
Phase 1
498
Meldola, Milan, Rozzano (MI), Pisa
2020-07-29
Recruiting
Web-based International Register of Emergency Surgery and Trauma
NCT03643718Acute Appendicitis, Acute Cholecystitis, Acute Diverticulitis, Post-operative Complications
A.O. Ospedale Papa Giovanni XXIII
Observational
10,000
Pisa
2020-07
Active, closed
Actelion
Phase 3
935
Milan, Modena, Nuoro, Pavia, Pisa, Roma
2020-06-30
Active, closed
Shanghai Junshi Bioscience Co., Ltd.
Phase 3
530
Milan, Naples, Pisa, Tortona, Verona
2020-06-29
Active, closed
Astellas Pharma Global Development, Inc.
Phase 3
886
Areezo, Candiolo, Cremona, Genova, Meldola, Milan, Pisa, Terni
2020-03-30
Active, closed
Loxo Oncology, Inc.
Phase 3
291
Naples, Rome, Milan, Turin, Pisa, Siena, Padova, Catania
2020-02-11
Active, closed
Takeda
Phase 3
354
Naples, Meldola, Milan, Orbassano, Aviano, Pisa, Parma, Ravenna
2020-01-10
Active, closed
Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)
NCT04185883Advanced Solid Tumors, Kirsten Rat Sarcoma (KRAS) pG12C Mutation
DrugsBI 1701963·TNO155·Afatinib·Sotorasib
Amgen
Phase 1
610
Milan, Pisa, Verona
2019-12-17
Recruiting
ALFAOMEGA Master Observational Trial
NCT04120935Colorectal Cancer
IFOM ETS - The AIRC Institute of Molecular Oncology
Observational
3,000
Biella, Milan, Padova, Perugia, Pisa, Ravenna, Candiolo, Orbassano
2019-10-15
Active, closed
BeOne Medicines
Phase 3
510
Alessandria, Bologna, Genova, Milan, Novara, Palermo, Pisa, Ravenna
2019-08-20
Active, closed
Università Vita-Salute San Raffaele
Not applicable
2,000
Cotignola, Catania, Lecce, Milan, Padua, Pisa, Potenza, Rome
2019-04-15
Active, closed
Madrigal Pharmaceuticals, Inc.
Phase 3
1,759
Messina, Milan, Novara, Palermo, Roma, Bergamo, Florence, Pisa
2019-03-28
Active, closed
Eisai Inc.
Phase 3
1,906
Tricase, Cefalù, Genova, Milan, Monza, Naples, Perugia, Pisa
2019-03-27
Active, closed
Institut de Recherches Internationales Servier
Phase 3
856
Cagliari, Cremona, Naples, Padova, Pisa, Potenza, Reggio Emilia, Roma
2019-03-21
Active, closed
Xenon Pharmaceuticals Inc.
Phase 2
325
Bologna, Catanzaro, Milan, Pavia, Pisa, Reggio Calabria, Roma
2019-01-30
Active, closed
Janssen Research & Development, LLC
Phase 3
765
Faenza, Milan, Naples, Padova, Parma, Perugia, Pisa, Roma
2019-01-25
Active, closed
AstraZeneca
Phase 3
724
Arezzo, Brescia, Milan, Pisa
2018-11-30
Active, closed
Exelixis
Phase 3
187
Viagrande, Catania, Meldola, Genova, Rozzano, Pisa, Torino, Milan
2018-10-05
Active, closed
Eli Lilly and Company
Phase 3
1,058
Catanzaro, Genova, Pisa, Rho, Roma, Rome, Rozzano, Torino
2018-07-18
Recruiting
Xynomic Pharmaceuticals, Inc.
Phase 3
413
Candiolo, Catania, Meldola (FC), Milan, Naples, Novara, Pavia, Pisa
2018-07-17
Active, closed
A Study of Zolbetuximab (IMAB362) in Adults With Gastric Cancer
NCT03505320Pharmacokinetics of Zolbetuximab, Gastric Cancer, Gastro-esophageal Junction (GEJ) Cancer, Pharmacokinetics of Oxaliplatin
DrugsZolbetuximab·Folinic acid·Fluorouracil·Leucovorin
Astellas Pharma Global Development, Inc.
Phase 2
143
Milan, Naples, Padova, Pisa
2018-06-29
Recruiting
University of Pisa
Not applicable
400
Pisa
2018-06-07
Active, closed
Cardiovalve Ltd.
Not applicable
30
Cotignola, Massa, Milan, Pisa
2018-04-23
Recruiting
Registry for Patients With Lipodystrophy
NCT03553420Lipodystrophy Acquired, Lipodystrophy Congenital
University of Ulm
Observational
5,000
Bologna, Milan, Novara, Palermo, Pisa, Roma
2017-12-16
Active, closed
AstraZeneca
Phase 3
1,324
Benevento, Meldola, Milan, Naples, Perugia, Pisa, Roma, Rozzano
2017-10-11
Active, closed
Murdoch Childrens Research Institute
Phase 3
450
Alessandria, Bologna, Florence, Genova, Milan, Pisa, Roma
2017-08-10
Recruiting
Italian Sarcoma Group
Not applicable
100
Milan, Bologna, Florence, Pavia, Pisa, Rome, Trento
2017-03-16
Recruiting
MEASuRE: Metreleptin Effectiveness And Safety Registry
NCT02325674Generalised Lipodystrophy, Partial Lipodystrophy
DrugMetreleptin
Chiesi Farmaceutici S.p.A.
Observational
100
Bologna, Pisa, Roma, Novara
2016-10-11
Active, closed
NeuroDerm Ltd.
Phase 2
214
Chieti, Pisa, Rome, Venice
2016-05-04
Recruiting
University of Pisa
Not applicable
800
Pisa
2016-01-11
Active, closed
Hoffmann-La Roche
Phase 2
534
Naples, Rome, Milan, Pisa, Perugia, Padova
2015-11-19
Active, closed
Medtronic
Observational
3,100
Bari, Bologna, Brescia, Cotignola, Milan, Pisa, Roma
2015-07
Active, closed
Ischaemic PReconditioning In Non Cardiac surgEry
NCT02427867Myocardial Ischemia, Surgery
Università Vita-Salute San Raffaele
Not applicable
1,217
Rozzano, Busto Arsizio, Asti, Florence, Genova, Milan, Naples, Pisa
2015-04
Active, closed
Exelixis
Phase 4
247
Catania, Roma, Siena, Pisa, Milan, Padua, Torino
2015-02-25
Active, closed
Hoffmann-La Roche
Phase 3
154
Bari, Bologna, Meldola, Reggio Emilia, Milan, Monza, Pisa
2015-02-02
By invitation
Registry of Patients With Hypophosphatasia
NCT02306720Hypophosphatasia (HPP)
Alexion Pharmaceuticals, Inc.
Observational
1,571
Sesto Fiorentino, Milan, Florence, Pisa, Rome, San Giovanni Rotondo
2015-01-20
Active, closed
Universitätsklinikum Hamburg-Eppendorf
Phase 3
789
Padova, Pisa, Rome, Milan
2014-04
Active, closed
Novartis Pharmaceuticals
Phase 1/2
259
Pisa
2013-10-22
Recruiting
St. Anna Kinderkrebsforschung
Phase 2/3
1,800
Bologna, Florence, Genoa, Monza, Naples, Padova, Pavia, Pisa
2013-04
Recruiting
Boston Scientific Corporation
Observational
4,800
Pavia, Pisa
2012-11-19
Active, closed
A Prospective, Clinical Investigation of the Vanguard 360 Revision Knee
NCT01542580Osteoarthritis, Rheumatoid Arthritis, Traumatic Arthritis, Post Traumatic Deformity
Zimmer Biomet
Observational
255
Milan, Pisa
2012-03
Active, closed
Fondazione del Piemonte per l'Oncologia
Observational
2,500
Aosta, Bologna, Candiolo, Genova, Milan, Orbassano, Padova, Pisa
2011-03-30
Active, closed
Memorial Sloan Kettering Cancer Center
Phase 3
220
Pisa
2010-10
Active, closed
Continuum Ceramic on Ceramic Bearing Post Market Clinical Follow-Up Study
NCT03343171Osteoarthritis, Avascular Necrosis, Inflammatory Arthritis, Post-traumatic Arthritis
Zimmer Biomet
Observational
203
Pisa, Rome
2010-09-15
Recruiting
Assessment of Transcatheter Edge-to-Edge Repair in Atrial Functional Mitral Regurgitation (ATRIAL-MR)
NCT06911099Atrial Functional Mitral Regurgitation, Mitral Insufficiency
University Hospital of Cologne
Observational
1,000
Brescia, Milan, Pisa
2010-01-01
Recruiting
Global Registry and Natural History Study for Mitochondrial Disorders
NCT05554835Mitochondrial Diseases, Kearns-Sayre Syndrome, MIDD, SANDO
LMU Klinikum
Observational
6,000
Bologna, Brescia, Cagliari, Florence, Genova, Messina, Milan, Pisa
2009-02-01
Rows per page Showing 1–393 of 393
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 9 October 2026. https://priyalifescience.com/clinical-trials-italy/city/pisa

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,778 studies in total at the last sync on 08 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 393 of those studies with a site in Pisa.

How many clinical trials are recruiting in Pisa?

194 of the 393 studies on this page are recruiting new participants as of the 08 Oct 2026, 03:19 UTC sync. A further 20 have not yet opened recruitment, 164 are active but closed to new participants, and 15 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Pisa), 393 studies
PhaseStudiesRecruitingShare
Phase 31717643.5%
Observational765119.3%
Phase 2592115%
Not applicable472812%
Phase 1/221115.3%
Phase 2/3741.8%
Phase 1611.5%
Phase 4621.5%

Most active sponsors

Lead sponsors with the most studies (Pisa)
Lead sponsorStudiesRecruiting
AstraZeneca2312
University of Pisa2013
Bristol-Myers Squibb179
Novartis Pharmaceuticals114
GlaxoSmithKline105
IRCCS Fondazione Stella Maris106
Janssen Research & Development, LLC105
Eli Lilly and Company96
Merck Sharp & Dohme LLC97
Amgen82
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.